About Obsurge Biotech
Obsurge Biotech is a Healthcare company based in Delhi (India) founded in 2002. It develops and manufactures healthcare products focused on cardiology, dentistry, and other therapeutic areas. It operates on a B2B model. The company has 606 employees. Its Indian entity Obsurge Biotech Limited reported revenue of ₹72.73 Cr. Its focus areas include Biotechnology, Medical Products and Cardiology and Dentistry. Its competitors include NeuWave, KLOwen, Aibo Medical, The InterMed Group and Panorama Eyecare and 5 more; 6 of its 10 listed competitors have raised funding.
Company details
Obsurge Biotech, established in 2002, excels in providing healthcare solutions, advancing biotech innovations, medical products, and cardiology and dentistry. Develops and manufactures healthcare products focused on cardiology, dentistry, and other therapeutic areas. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Delhi, India
- Employees 606
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website obsurge.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Obsurge Biotech Limited
- Date of Incorporation 04 Jan, 2002
- Jurisdiction Delhi, India
- Annual Revenue₹72.73 Cr
FY 2025 · +8% YoY
- Net Profit₹6.25 Cr
FY 2025 · 9% margin
- EBITDA₹9.22 Cr
FY 2025 · 13% margin
- Employee Count606
Associated legal entities of Obsurge Biotech
Obsurge Biotech operates through Obsurge Biotech Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Obsurge Biotech Limited CIN U24232DL2002PLC113701 | Active | 04 Jan 2002 | Delhi, Delhi | ₹72.7 Cr | 606 | 4 | View details |
Apps and channels of Obsurge Biotech
its YouTube channel obsurge biotech ltd has 94 subscribers.
Board of directors of Obsurge Biotech Limited (Obsurge Biotech)
Obsurge Biotech Limited is the primary company behind Obsurge Biotech. The board of Obsurge Biotech Limited currently have 4 directors; the longest-serving is Jaswant Singh Chauhan, appointed in 2002. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jaswant Singh Chauhan DIN 00222504 | Director | 04 Jan 2002 | 24 yrs 9 mo | Obsurge Biotech Limited |
| Latish Malhotra DIN 00238260 | Whole-time director | 04 Jan 2002 | 24 yrs 9 mo | Obsurge Biotech Limited |
| Avijit Chauhan DIN 01935991 | Managing Director | 07 Jan 2008 | 18 yrs 9 mo | Obsurge Biotech Limited |
| Amin Ul Aziz DIN 07084459 | Director | 03 Apr 2015 | 11 yrs 6 mo | Obsurge Biotech Limited |
Financials of Obsurge Biotech
Figures of Obsurge Biotech Limited, the primary company behind Obsurge Biotech, for FY 2025. Revenue was ₹72.73 Cr (+8% year on year). Net profit was ₹6.25 Cr (9% margin). EBITDA was ₹9.22 Cr (13% margin). Revenue has grown at a compounded annual rate of +13% over three years and +10% over five years.
- ₹72.73 CrRevenue · FY 2025 · +8% YoY
- ₹6.25 CrNet profit · 9% margin
- ₹9.22 CrEBITDA · 13% margin
- ₹28.2 LakhPaid-up capital
- 606Employees (provident fund records)
- +13%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Obsurge Biotech Limited are on its company page.
Detailed financial statements for Obsurge Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Obsurge Biotech
Obsurge Biotech has 10 listed competitors in our database, 6 of them funded. They include NeuWave, KLOwen, Aibo Medical, The InterMed Group and Panorama Eyecare, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neuwave.com | 2004 | Madison, United States | $52.68M | – | Microwave ablation systems for soft tissue and cancer are developed. | |
| klowenortho.com | 2019 | Richardson, United States | $30.09M | – | Digital tools for orthodontists are provided by KLOwen. | |
| abrobo.com | 2020 | Shenzhen, China | $32.93M | – | Vascular interventional surgery robot systems are developed by the company. | |
| intermed1.com | 1996 | Alachua, United States | – | 127 | Healthcare technology management services and equipment are provided. | |
| panoramaeyecare.com | 2021 | Fort Collins, United States | $150M | – | Physician-led management services for eye care professionals are provided. | |
| apexphysicspartners.com | 2019 | Towson, United States | – | 157 | Medical center equipment services are provided by Apex Physics Partners. | |
| kunyamedical.com | 2009 | Shanghai, China | $20.64M | – | Provider of medical equipment maintenance services | |
| gzredpine.com | 2015 | Guangdong, China | – | – | Medical equipment is supplied by Ruipai in Guangdong, China. | |
| blockimaging.com | 1997 | Holt, United States | – | 222 | Medical imaging equipment management services are provided to healthcare providers. | |
| opkit.co | 2021 | New York, United States | $1.13M | – | An implant case costing tool is provided for physicians. |
Detailed competitors of Obsurge Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
10 companies that operate in the same segment as Obsurge Biotech (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | 252 | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Obsurge Biotech
Obsurge Biotech was founded in 2002.
Obsurge Biotech is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Obsurge Biotech has 606 employees.
The primary company behind Obsurge Biotech, Obsurge Biotech Limited, reported revenue of ₹72.73 Cr for FY 2025, up 8% year on year.
Obsurge Biotech, established in 2002, excels in providing healthcare solutions, advancing biotech innovations, medical products, and cardiology and dentistry. Develops and manufactures healthcare products focused on cardiology, dentistry, and other therapeutic areas. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Obsurge Biotech's top competitors include KLOwen, NeuWave and The InterMed Group.
Obsurge Biotech operates through Obsurge Biotech Limited.
The legal entities of Obsurge Biotech currently have 4 directors, including Avijit Chauhan, Amin Ul Aziz, Jaswant Singh Chauhan and others.